Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: E_K_S who wrote (38637)	7/31/2010 10:15:24 PM
From: voodooist	Respond to of 78748

Thanks EKS for your PFE update/analysis. Not a lot of happy investors in this one. I have a full position, so am not likely to add (unless it drops to the 3's <ng>.

To: E_K_S who wrote (38637)	8/3/2010 9:29:40 AM
From: E_K_S	Respond to of 78748

Drugmaker Pfizer posts 9 percent jump in 2Q profit Drugmaker Pfizer posts 9 percent jump in 2Q profit, beats forecasts, on new revenue from Wyeth finance.yahoo.com from the article:"...Pfizer, the world's biggest drugmaker by sales, said revenue totaled $17.33 billion, up 58 percent from $10.98 billion in 2009's second quarter.,,," ================================================================== Company integrating their Wyeth acquisition. If sales and earnings have stabilized, PFE remains a good value candidate at current levels. EKS